LexAurum Advisors
CVS icon

LexAurum Advisors’s CVS Health CVS Stock Holding History

LexAurum Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$361K Sell
4,208
-7
-0.2% -$685 0.04% 311
2026
Q2 		$436K Sell
4,215
-318
-7% -$28.4K 0.05% 271
2026
Q1 		$326K Buy
+4,533
New +$349K 0.04% 310
2025
Q3 		$381K Sell
5,049
-590
-10% -$40.4K 0.05% 251
2025
Q2 		$389K Sell
5,639
-155
-3% -$10.2K 0.06% 228
2025
Q1 		$393K Sell
5,794
-133
-2% -$7.96K 0.08% 225
2024
Q4 		$266K Buy
5,927
+83
+1% +$4.66K 0.05% 280
2024
Q3 		$367K Buy
5,844
+10
+0.2% +$583 0.08% 210
2024
Q2 		$345K Buy
5,834
+31
+0.5% +$1.94K 0.08% 206
2024
Q1 		$463K Sell
5,803
-983
-14% -$75.1K 0.12% 160
2023
Q4 		$536K Buy
6,786
+599
+10% +$42.6K 0.14% 145
2023
Q3 		$432K Sell
6,187
-5
-0.1% -$354 0.13% 158
2023
Q2 		$428K Buy
6,192
+1,233
+25% +$87.7K 0.13% 149
2023
Q1 		$368K Sell
4,959
-94
-2% -$7.88K 0.12% 156
2022
Q4 		$471K Buy
5,053
+104
+2% +$10K 0.17% 124
2022
Q3 		$472K Buy
4,949
+159
+3% +$15.7K 0.18% 120
2022
Q2 		$444K Buy
4,790
+4
+0.1% +$390 0.17% 128
2022
Q1 		$484K Sell
4,786
-96
-2% -$10.1K 0.16% 128
2021
Q4 		$504K Buy
4,882
+4
+0.1% +$370 0.16% 134
2021
Q3 		$414K Buy
4,878
+290
+6% +$24.3K 0.12% 185
2021
Q2 		$383K Buy
4,588
+605
+15% +$49.5K 0.11% 195
2021
Q1 		$300K Sell
3,983
-220
-5% -$16K 0.1% 200
2020
Q4 		$287K Sell
4,203
-193
-4% -$12.6K 0.1% 190
2020
Q3 		$257K Sell
4,396
-605
-12% -$37.6K 0.11% 187
2020
Q2 		$325K Buy
5,001
+131
+3% +$8.25K 0.18% 128
2020
Q1 		$289K Buy
4,870
+158
+3% +$10.5K 0.2% 113
2019
Q4 		$350K Buy
4,712
+1,212
+35% +$85.1K 0.17% 134
2019
Q3 		$221K Buy
+3,500
New +$207K 0.13% 168

Other funds holding CVS

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

LexAurum Advisors's CVS Position: Q3 2026 in Review

LexAurum Advisors reduced its CVS Health (CVS) stake by 0.17% in Q3 2026, selling an estimated $685 and leaving 4,208 shares worth $361K. The position accounts for 0.04% of the portfolio, ranked #311.

LexAurum Advisors first reported a position in CVS in Q3 2019 and has held it in 28 quarters since. The position peaked at $536K in Q4 2023. 1,072 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • LexAurum Advisors held 4,208 shares of CVS Health worth $361K as of Q3 2026.
  • LexAurum Advisors sold 7 CVS Health shares in Q3 2026, an estimated $685.
  • CVS Health made up 0.04% of LexAurum Advisors's portfolio in Q3 2026, its #311 holding.
  • LexAurum Advisors first reported a position in CVS Health in Q3 2019 and has held it in 28 quarters since.
  • LexAurum Advisors's CVS Health position peaked at $536K in Q4 2023.
  • 1,072 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on LexAurum Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.